Aquestive Therapeutics, Inc.
NASDAQ:AQST
Overview | Financials
Company Name | Aquestive Therapeutics, Inc. |
Symbol | AQST |
Currency | USD |
Price | 3.52 |
Market Cap | 320,947,264 |
Dividend Yield | 0% |
52-week-range | 1.95 - 6.23 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Daniel Barber |
Website | https://www.aquestive.com |
An error occurred while fetching data.
About Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD